Clark Capital Management Group, Inc. United Therapeutics Corp Transaction History

Clark Capital Management Group, Inc.

$13.8 Billion
Q4 2024

A detailed history of Clark Capital Management Group, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 189,341 shares of UTHR stock, worth $60.6 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

189,341

Previous 182,288 3.87%

Holding current value

$60.6 Million

Previous $65.3 Million 2.27%

% of portfolio

0.48%

Previous 0.46%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$348.66 - $410.0 $2.46 Million - $2.89 Million	7,053 Added 3.87%	189,341 $66.8 Million
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $1.98 Million - $2.32 Million	6,375 Added 3.62%	182,288 $65.3 Million
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $14 Million - $19.6 Million	61,318 Added 53.51%	175,913 $56 Million
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $636,495 - $753,520	3,020 Added 2.71%	114,595 $26.3 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $4.32 Million - $5.17 Million	-20,120 Reduced 15.28%	111,575 $24.5 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $6.72 Million - $7.87 Million	31,721 Added 31.73%	131,695 $29.7 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $245,407 - $278,656	1,196 Added 1.21%	99,974 $22.1 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $569,535 - $738,478	2,674 Added 2.78%	98,778 $22.1 Million
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $17.2 Million - $23.4 Million	83,425 Added 657.98%	96,104 $26.7 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $42,489 - $51,031	209 Added 1.68%	12,679 $2.66 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $1,398 - $1,929	-8 Reduced 0.06%	12,470 $2.94 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $1.01 Million - $1.3 Million	-6,079 Reduced 32.76%	12,478 $2.24 Million
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $140,820 - $165,085	-764 Reduced 3.95%	18,557 $4.01 Million
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $143,708 - $171,689	799 Added 4.31%	19,321 $3.57 Million
Q2 2021 Aug 02, 2021	BUY	$170.47 - $211.93 $441,858 - $549,322	2,592 Added 16.27%	18,522 $3.32 Million
Q1 2021 May 17, 2021	SELL	$153.94 - $174.85 $1.16 Million - $1.31 Million	-7,511 Reduced 32.04%	15,930 $2.67 Million
Q4 2020 Jan 26, 2021	BUY	$101.87 - $151.79 $2.39 Million - $3.56 Million	23,441 New	23,441 $3.56 Million
Q3 2020 Nov 12, 2020	SELL	$99.9 - $121.13 $2.55 Million - $3.09 Million	-25,510 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $754,625 - $1.02 Million	-8,137 Reduced 24.18%	25,510 $3.09 Million
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $587,644 - $853,820	7,402 Added 28.2%	33,647 $3.19 Million
Q4 2019 Jan 27, 2020	BUY	$78.31 - $95.34 $2.06 Million - $2.5 Million	26,245 New	26,245 $2.31 Million

Others Institutions Holding UTHR

# of Institutions

724

Shares Held

58.5M

Call Options Held

123K

Put Options Held

104K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.

Account

Clark Capital Management Group, Inc. United Therapeutics Corp Transaction History